Out of a population of 150 LifeMD patients, on average, patients on Triple Therapy lost 7 pounds within the first three months of treatment.
In the Flinders University study, of the 6954 women first prescribed GLP-1 receptor agonists during 2022, 90.5% did not have type 2 diabetes, suggesting that many were using the medication for weight loss
In the perimenopausal and menopausal phase, up to 70% of women experience weight gain, newly hired Chief Medical Officer Dr
The more responsible approach is to address the systems that actually shape brain aging: metabolic health, cardiovascular risk, sleep, movement, body composition, inflammation, sensory health, hormones, nutrition, and long-term function
Fifteen additional minutes of application of GLP-1 or GLP-1MK-801 were conducted without recording to minimize exposure to fluorescent light to reduce bleaching of the fluorescent indicator